556 results on '"Delden, A. van"'
Search Results
2. Changes in the use of continuous deep sedation in the Netherlands
- Author
-
Delden, J.J.M. van, Heide, A. van der, Rietjens, J.A.C., Thiel, G.J.M.W. van, Heijltjes, Madelon Tessa, Delden, J.J.M. van, Heide, A. van der, Rietjens, J.A.C., Thiel, G.J.M.W. van, and Heijltjes, Madelon Tessa
- Published
- 2024
3. Local Identification of Equatorial Kelvin Waves in Real-Time Operational Forecasts
- Author
-
Correia de Paiva Bulas Cruz, Joao, Delden, A.J. van (Thesis Advisor), Correia de Paiva Bulas Cruz, Joao, and Delden, A.J. van (Thesis Advisor)
- Abstract
Equatorial Kelvin waves (KWs) are associated with a variety of equatorial atmospheric phenomena. They are related to tropical convection, cloud and precipitation variability, tropical cyclogenisis, the onset of monsoon season over Africa and India, and even equatorial oscillation patterns, namely the quasi-biennial oscillation (QBO) and the Madden-Julian oscillation (MJO). As such, if operational forecasts are to improve near the tropics, it is important that they correctly represent KWs. This paper aims at developing a novel methodology for identifying KWs in real-time operational forecasts at specific longitudes using only the meridional structures of the solutions to the free Laplace tidal equations, known as Hough vector functions. The main advantages of this newly proposed methodology are that 1) it can univocally identify Kelvin waves at given longitudes and 2) very low computational cost is needed to apply it to real-time operational forecasts. The application of the method to 2015-2017 ECMWF analysis and operational forecast data reveals a topography related bias in the representation of the amplitude and phase of the Kelvin waves by the ECMWF operational forecast model.
- Published
- 2024
4. 'Completed life': Older adults who have a death wish without being severely ill
- Author
-
Delden, J.J.M. van, Leget, C.J.W., Thiel, G.J.M.W. van, Wijngaarden, E.J. van, Zomers, Margot Lisa, Delden, J.J.M. van, Leget, C.J.W., Thiel, G.J.M.W. van, Wijngaarden, E.J. van, and Zomers, Margot Lisa
- Published
- 2024
5. Adjuvant holmium-166 radioembolization after radiofrequency ablation in early-stage hepatocellular carcinoma patients: a dose-finding study (HORA EST HCC trial).
- Author
-
Hendriks, P., Rietbergen, D.D.D., Erkel, A.R. van, Coenraad, M.J., Arntz, M., Bennink, R.J., Braat, A.E., Crobach, S., Delden, O.M. van, Dibbets-Schneider, P., Hulle, T. van der, Klümpen, H.J., Meer, R.W. van der, Nijsen, J.F.W., Rijswijk, C.S.P. van, Roosen, J., Ruijter, B.N., Smit, F., Stam, M.K., Takkenberg, R.B., Tushuizen, M.E., Velden, F.H.P. van, Geus-Oei, L.F. de, Burgmans, M.C., Hendriks, P., Rietbergen, D.D.D., Erkel, A.R. van, Coenraad, M.J., Arntz, M., Bennink, R.J., Braat, A.E., Crobach, S., Delden, O.M. van, Dibbets-Schneider, P., Hulle, T. van der, Klümpen, H.J., Meer, R.W. van der, Nijsen, J.F.W., Rijswijk, C.S.P. van, Roosen, J., Ruijter, B.N., Smit, F., Stam, M.K., Takkenberg, R.B., Tushuizen, M.E., Velden, F.H.P. van, Geus-Oei, L.F. de, and Burgmans, M.C.
- Abstract
Contains fulltext : 307395.pdf (Publisher’s version ) (Open Access), PURPOSE: The aim of this study was to investigate the biodistribution of (super-)selective trans-arterial radioembolization (TARE) with holmium-166 microspheres ((166)Ho-MS), when administered as adjuvant therapy after RFA of HCC 2-5 cm. The objective was to establish a treatment volume absorbed dose that results in an absorbed dose of ≥ 120 Gy on the hyperemic zone around the ablation necrosis (i.e., target volume). METHODS: In this multicenter, prospective dose-escalation study in BCLC early stage HCC patients with lesions 2-5 cm, RFA was followed by (super-)selective infusion of (166)Ho-MS on day 5-10 after RFA. Dose distribution within the treatment volume was based on SPECT-CT. Cohorts of up to 10 patients were treated with an incremental dose (60 Gy, 90 Gy, 120 Gy) of (166)Ho-MS to the treatment volume. The primary endpoint was to obtain a target volume dose of ≥ 120 Gy in 9/10 patients within a cohort. RESULTS: Twelve patients were treated (male 10; median age, 66.5 years (IQR, [64.3-71.7])) with a median tumor diameter of 2.7 cm (IQR, [2.1-4.0]). At a treatment volume absorbed dose of 90 Gy, the primary endpoint was met with a median absorbed target volume dose of 138 Gy (IQR, [127-145]). No local recurrences were found within 1-year follow-up. CONCLUSION: Adjuvant (super-)selective infusion of (166)Ho-MS after RFA for the treatment of HCC can be administered safely at a dose of 90 Gy to the treatment volume while reaching a dose of ≥ 120 Gy to the target volume and may be a favorable adjuvant therapy for HCC lesions 2-5 cm. TRIAL REGISTRATION: Clinicaltrials.gov NCT03437382 . (registered: 19-02-2018)., 01 juni 2024
- Published
- 2024
6. Do Infectious Diseases After Kidney Retransplantation Differ From Those After First Kidney Transplantation?
- Author
-
Kusejko, Katharina, Neofytos, Dionysios, Delden, Christian van, Hirsch, Hans H, Meylan, Pascal, Boggian, Katia, Hirzel, Cedric, Garzoni, Christian, Sidler, Daniel, Schnyder, Aurelia, Schaub, Stefan, Golshayan, Déla, Haidar, Fadi, Bonani, Marco, Kouyos, Roger D, Mueller, Nicolas J, Schreiber, Peter W, and Study, the Swiss Transplant Cohort
- Abstract
Background Infectious diseases (IDs) are highly relevant after solid organ transplantation in terms of morbidity and mortality, being among the most common causes of death. Patients undergoing kidney retransplantation (re-K-Tx) have been already receiving immunosuppressive therapy over a prolonged period, potentially facilitating subsequent infections. Comparing ID events after re-K-Tx and first kidney transplantation (f-K-Tx) can delineate patterns and risks of ID events associated with prolonged immunosuppression. Methods We included adult patients with records on f-K-Tx and re-K-Tx in the Swiss Transplant Cohort Study. We analyzed ID events after f-K-Tx and re-K-Tx within the same patients and compared infection rates, causative pathogens, and infection sites. Recurrent time-to-event analyses were performed for comparison of infection rates. Results A total of 59 patients with a median age of 47 years (range, 18–73) were included. Overall, 312 ID events in 52 patients occurred. In multivariable recurrent event modeling, the rate of ID events was significantly lower after re-K-Tx (hazard ratio, 0.70; P =.02). More bacterial (68.9% vs 60.4%) and fungal (4.0% vs 1.1%) infections were observed after f-K-Tx but fewer viral infections (27.0% vs 38.5%) as compared with re-K-Tx (P =.11). After f-K-Tx, urinary and gastrointestinal tract infections were more frequent; after re-K-Tx, respiratory tract and surgical site infections were more frequent (P <.001). Conclusions ID events were less frequent after re-K-Tx. Affected sites differed significantly after f-K-Tx vs re-K-Tx. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF
7. A Tunable Dielectric Resonator Oscillator with Phase-Locked Loop Stabilization for THz Time Domain Spectroscopy Systems
- Author
-
KAESBACH, Robin, primary, DELDEN, Marcel VAN, additional, and MUSCH, Thomas, additional
- Published
- 2023
- Full Text
- View/download PDF
8. Beeldvormende diagnostiek
- Author
-
Delden, O.M. van, Maas, M., Laméris, J.S., Stehouwer, C.D.A., editor, and Koopmans, R.P., editor
- Published
- 2017
- Full Text
- View/download PDF
9. How Gulf-Stream SST-fronts influence Atlantic winter storms: Results from a downscaling experiment with HARMONIE to the role of modified latent heat fluxes and low-level baroclinicity
- Author
-
Vries, Hylke de, Scher, Sebastian, Haarsma, Rein, Drijfhout, Sybren, and Delden, Aarnout van
- Published
- 2019
- Full Text
- View/download PDF
10. Psychosocial functioning of parents of Dutch long-term survivors of childhood cancer
- Author
-
Gorp, M. van, Joosten, M.M.H., Maas, A., Drenth, B.L., Aa-van Delden, A. van der, Kremer, L.C.M., Dulmen-den Broeder, E. van, Tissing, W.J.E., Loonen, J.J., Pal, H.J.H. van der, Vries, A.C.H. de, Heuvel-Eibrink, M.M. van den, Ronckers, C., Bresters, D., Louwerens, M., Neggers, S.J.C.C.M., Heiden-van der Loo, M. van der, Maurice-Stam, H., Grootenhuis, M.A., Dutch LATER Study Grp, Pediatrics, Guided Treatment in Optimal Selected Cancer Patients (GUTS), Paediatric Oncology, Paediatric Pulmonology, CCA - Cancer Treatment and Quality of Life, ARD - Amsterdam Reproduction and Development, Child and Adolescent Psychiatry & Psychosocial Care, CCA - Cancer Treatment and quality of life, and Amsterdam Reproduction & Development (AR&D)
- Subjects
parents ,Experimental and Cognitive Psychology ,survivors of childhood cancer ,pediatric oncology ,Healthcare improvement science Radboud Institute for Health Sciences [Radboudumc 18] ,health-related quality of life ,Psychiatry and Mental health ,All institutes and research themes of the Radboud University Medical Center ,Oncology ,SDG 3 - Good Health and Well-being ,psychosocial outcomes ,illness cognitions ,post-traumatic growth ,psycho-oncology ,post-traumatic stress - Abstract
Contains fulltext : 291391.pdf (Publisher’s version ) (Open Access) OBJECTIVE: To describe health-related quality of life (HRQoL), post-traumatic stress and post-traumatic growth of parents of long-term survivors of childhood cancer (CCS) and study associated factors. METHODS: Parents of survivors of the Dutch Childhood Cancer Survivor Study LATER cohort below 30 years and diagnosed 1986-2001 were invited to complete the TNO-AZL Questionnaire for Adult's HRQoL (e.g., sleep and aggressive emotions), Self-Rating Scale for Post-traumatic Stress Disorder, Post-traumatic Growth Inventory, and Illness Cognition Questionnaire. HRQoL domain scores were compared to references using Mann-Whitney U tests. Correlations between post-traumatic stress, growth and HRQoL were evaluated. Medical characteristics of their child and illness cognitions were studied as associated factors of HRQOL, post-traumatic stress and growth. p
- Published
- 2023
11. Revisiting Cytomegalovirus Serology in Allogeneic Hematopoietic Cell Transplant Recipients.
- Author
-
Portillo, Vera, Masouridi-Levrat, Stavroula, Royston, Léna, Yerly, Sabine, Schibler, Manuel, Mappoura, Maria, Morin, Sarah, Giannotti, Federica, Mamez, Anne-Claire, Delden, Christian van, Chalandon, Yves, and Neofytos, Dionysios
- Subjects
HOMOGRAFTS ,CYTOMEGALOVIRUS diseases ,BLOOD plasma ,SEROLOGY ,COMPARATIVE studies ,CELLS ,IMMUNITY ,DESCRIPTIVE statistics ,HEMATOPOIETIC stem cell transplantation ,DIAGNOSTIC errors ,LONGITUDINAL method ,PATIENT safety - Abstract
Background Allogeneic hematopoietic cell transplant recipients (allo-HCTRs) with positive cytomegalovirus (CMV) serology may have false-positive results due to blood product transfusion–associated passive immunity. Methods This single-center cohort study included allo-HCTRs with negative baseline (at malignancy diagnosis) CMV serology and indeterminate/low-positive (CMV IgG titer, ≥0.6–<50 U/mL) pretransplant CMV serology with negative pretransplant plasma CMV DNAemia. The CMV status of those patients was reclassified from R+ to R− (CMVR− reclassification group). We compared those patients to allo-HCTRs with negative (CMV IgG titer <0.6 U/mL) pretransplant CMV IgG (CMVR− group). We describe the number and type of patients whose pretransplant CMV status was reclassified from indeterminate/positive to negative. We reviewed all plasma CMV DNAemia tests performed during the first 6 months posttransplant in both groups to assess the safety of this approach. Results Among 246 (84.5%) of 291 transplanted patients identified as CMVR+ pretransplant, 60 (24.4%) were reclassified from CMV serology indeterminate (N:10)/low-positive (N:50) to R−. Only 1 of 60 patients (1.67%) in the CMVR− reclassification group versus 3 of 44 (6.8%; P =.30) in the CMVR− group developed CMV DNAemia during the follow-up period. There were no significant differences in the number of CMV DNAemia tests performed, CMV DNAemia range, and time posttransplant between the 2 groups. Conclusions One of 4 allo-HCT CMVR+ may be falsely flagged as R+, with significant impact on donor selection and prophylaxis administration. A 2-step approach including CMV serology testing at hematologic malignancy diagnosis in allo-HCT candidates and careful review of pretransplant CMV IgG titers may help correctly classify CMV serology status. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF
12. Seasonal controls on methane flux components in a boreal peatland – combining plant removal and stable isotope analyses.
- Author
-
Jentzsch, Katharina, Männistö, Elisa, Marushchak, Maija E., Korrensalo, Aino, Delden, Lona van, Tuittila, Eeva-Stiina, Knoblauch, Christian, and Treat, Claire C.
- Subjects
STABLE isotope analysis ,GREENHOUSE gas mitigation ,WETLANDS ,METHANE ,ATMOSPHERIC methane ,PEAT mosses ,PHOSPHORIMETRY - Abstract
Wetlands are the largest natural source of atmospheric methane and highly vulnerable to climate change. In our study we aim to better understand the environmental controls on the strength and seasonal variation of methane flux components from hollows, typically the high-emitting wettest microtopographic features in a boreal bog. We measured methane fluxes from intact vegetation as well as on vegetation removal treatments and analyzed pore water methane concentrations and stable carbon isotopes of dissolved and emitted methane. Using these data, we quantified the rates of total methane emission, methane oxidation and plant-mediated methane transport for the summer and shoulder seasons of 2021 and 2022. Total methane emissions from areas with intact vegetation range from 13 to 2171 mgCH
4 m–2 d–1 during shoulder seasons and summer months and are mainly controlled by the leaf area of aerenchymatous plants. Methane oxidation in the Sphagnum moss layer decreases total methane emissions by 82 ± 20 % while transport of methane through aerenchymatous plants increases methane emissions by 80 ± 22 %. Both methane oxidation and plant-mediated methane transport rates follow a seasonal cycle with lower but still significant rates during the shoulder seasons compared to the summer months. As a net effect, the presence of Sphagnum mosses and vascular plants reduces methane emissions from the study site. This balance, however, appears to be highly sensitive to climate change, i.e. increasing soil temperatures and changing leaf area and composition of the wetland vegetation. The provided insights can help to improve the representation of environmental controls on the methane cycle and its seasonal dynamics in process-based models to more accurately predict future methane emissions from boreal peatlands. [ABSTRACT FROM AUTHOR]- Published
- 2024
- Full Text
- View/download PDF
13. Hepatitis E Virus Infection Epidemiology in Recipients of Allogeneic Hematopoietic Cell Transplant.
- Author
-
Courjon, Johan, Portillo, Vera, Yerly, Sabine, Vetter, Pauline, Schibler, Manuel, Mappoura, Maria, Morin, Sarah, Giannotti, Federica, Mamez, Anne-Claire, Delden, Christian van, Kaiser, Laurent, Chalandon, Yves, Masouridi-Levrat, Stavroula, and Neofytos, Dionysios
- Subjects
HEPATITIS E virus ,BK virus ,POLYMERASE chain reaction ,VIRAL replication ,HEMATOPOIETIC stem cell transplantation ,EPIDEMIOLOGY - Abstract
Among 292 recipients of allogeneic hematopoietic cell transplant (2018–2022), 64 (21.9%) tested positive for anti–hepatitis E virus (HEV) immunoglobulin G. Among 208 recipients tested by plasma/serum HEV polymerase chain reaction (2012–2022), 3 (1.4%) primary HEV infections were diagnosed; in 1 patient, plasma HEV polymerase chain reaction relapsed positive for 100 days. HEV infection remains rare albeit associated with persistent viral replication. [ABSTRACT FROM AUTHOR]
- Published
- 2023
- Full Text
- View/download PDF
14. Routine Infectious Disease Consultation Prior to an Allogeneic Hematopoietic Cell Transplant.
- Author
-
Portillo, Vera, Masouridi-Levrat, Stavroula, Chalandon, Yves, Mappoura, Maria, Morin, Sarah, Marinosci, Annalisa, Giannotti, Federica, Mamez, Anne-Claire, Delden, Christian van, and Neofytos, Dionysios
- Subjects
COMMUNICABLE diseases ,DISEASE complications ,DIAGNOSIS methods - Abstract
Background A transplant infectious disease (TID) assessment is essential to select recipients for an allogeneic hematopoietic cell transplant (HCT) and tailor prophylactic and empirical treatment recommendations. Methods We performed a retrospective single-center study to describe our model of care based on a routine TID consultation prior to an allogeneic HCT between 2018 and 2022 in 292 adult (≥18-year-old) consecutive patients. We describe the performance of a TID consultation, arbitrarily defined as major (HCT postponement, procedure, cytomegalovirus [CMV] recipient serology reinterpretation) and minor interventions. Results Overall, 765 interventions were observed in 257 of 292 (88%) patients: 88 of 765 (11.5%) major and 677 of 765 (88.5%) minor interventions. Among major interventions, HCT was postponed in 8 of 292 (2.7%) patients and a procedure was requested in 18 of 292 (6.2%) patients. The CMV recipient serostatus was changed from indeterminate/low-titer positive to negative in 60 of 292 (20.5%) patients. Among 677 minor interventions, there were 68 (8.8%) additional consultations with other services requested, 260 (33.7%) additional diagnostic tests requested, 102 (13.2%) additional treatments recommended, 60 (7.8%) non-CMV serology reinterpretations performed, 115 (14.9%) deviations from routine anti-infective prophylaxis, and 72 (9.3%) deviations from routine empirical antibiotic treatment recommendations in case of neutropenic fever. Conclusions We are proposing a structured, clearly defined, and comprehensive pretransplant checklist for an effective assessment of infectious disease risks and complications prior to an allogeneic HCT. Further studies or experiences like ours could help to define a global strategy or new models of care to be implemented in HCT centers in the future. [ABSTRACT FROM AUTHOR]
- Published
- 2023
- Full Text
- View/download PDF
15. Self-efficacy of advanced cancer patients for participation in treatment related decision- making: the ACTION study.
- Author
-
Yildiz, Berivan, primary, Korfage, Ida J., additional, Deliens, Luc, additional, Preston, Nancy, additional, Miccinesi, Guido, additional, Ceh, Hana Kodba, additional, Pollock, Kristian, additional, Johnsen, Anna Thit, additional, Delden, Johannes van, additional, Rietjens, Judith, additional, and Heide, Agnes van der, additional
- Published
- 2023
- Full Text
- View/download PDF
16. Transarterial Chemoembolization With Drug-Eluting Beads Versus Stereotactic Body Radiation Therapy for Hepatocellular Carcinoma: Outcomes From a Multicenter, Randomized, Phase 2 Trial (the TRENDY Trial).
- Author
-
Méndez Romero, A., Holt, B. van der, Willemssen, F.E.J.A., Man, R.A. de, Heijmen, B.J.M., Habraken, S., Westerveld, H., Delden, O.M. van, Klümpen, H.J., Tjwa, E.T., Braam, P.M., Jenniskens, S.F.M., Vanwolleghem, T., Weytjens, R., d'Archambeau, O., Vos-Geelen, J. de, Buijsen, J., Leij, C. van der, Toom, W. den, Sprengers, D., Ijzermans, J.N.M., Moelker, A., Méndez Romero, A., Holt, B. van der, Willemssen, F.E.J.A., Man, R.A. de, Heijmen, B.J.M., Habraken, S., Westerveld, H., Delden, O.M. van, Klümpen, H.J., Tjwa, E.T., Braam, P.M., Jenniskens, S.F.M., Vanwolleghem, T., Weytjens, R., d'Archambeau, O., Vos-Geelen, J. de, Buijsen, J., Leij, C. van der, Toom, W. den, Sprengers, D., Ijzermans, J.N.M., and Moelker, A.
- Abstract
Contains fulltext : 296077.pdf (Publisher’s version ) (Open Access), PURPOSE: To compare transarterial chemoembolization delivered with drug eluting beads (TACE-DEB) with stereotactioc body radiation therapy (SBRT) in patients with hepatocellular carcinoma (HCC) in a multicenter randomized trial. METHODS AND MATERIALS: Patients were included if they were eligible for TACE. They could also be recruited if they required treatment prior to liver transplantation. A maximum of four TACE-DEB procedures and ablation after incomplete TACE-DEB were both allowed. SBRT was delivered in six fractions of 8-9Gy. Primary end point was time to progression (TTP). Secondary endpoints were local control (LC), overall survival (OS), response rate (RR), toxicity, and quality of life (QoL). The calculated sample size was 100 patients. RESULTS: Between May 2015 and April 2020, 30 patients were randomized to the study. Due to slow accrual the trial was closed prematurely. Two patients in the SBRT arm were considered ineligible leaving 16 patients in the TACE-DEB arm and 12 in the SBRT arm. Median follow-up was 28.1 months. Median TTP was 12 months for TACEDEB and 19 months for SBRT (p=0.15). Median LC was 12 months for TACE-DEB and >40 months (not reached) for SBRT (p=0.075). Median OS was 36.8 months for TACEDEB and 44.1 months for SBRT (p=0.36). A post-hoc analysis showed 100% for SBRT 1- and 2-year LC, and 54.4% and 43.6% for TACE-DEB (p=0.019). Both treatments resulted in RR>80%. Three episodes of possibly related toxicity grade ≥3 were observed after TACE-DEB. No episodes were observed after SBRT. QoL remained stable after both treatment arms. CONCLUSIONS: In this trial, TTP after TACE-DEB was not significantly improved by SBRT, while SBRT showed higher local antitumoral activity than TACE-DEB, without detrimental effects on OS, toxicity and QoL. To overcome poor accrual in randomized trials that include SBRT, and to generate evidence for including SBRT in treatment guidelines, international cooperation is needed.
- Published
- 2023
17. Psychosocial outcomes in long-term Dutch adult survivors of childhood cancer: The DCCSS-LATER 2 psycho-oncology study.
- Author
-
Maas, A, Maurice-Stam, H., Kremer, L.C.M., Aa-van Delden, A. van der, Dulmen-den Broeder, E. van, Tissing, W.J.E., Loonen, J.J., Pal, H.J.H. van der, Vries, A.C.H. de, Heuvel-Eibrink, M.M. van den, Ronckers, C., Neggers, S., Bresters, D., Louwerens, M., Heiden-van der Loo, M. van der, Gorp, M. van, Grootenhuis, M., Maas, A, Maurice-Stam, H., Kremer, L.C.M., Aa-van Delden, A. van der, Dulmen-den Broeder, E. van, Tissing, W.J.E., Loonen, J.J., Pal, H.J.H. van der, Vries, A.C.H. de, Heuvel-Eibrink, M.M. van den, Ronckers, C., Neggers, S., Bresters, D., Louwerens, M., Heiden-van der Loo, M. van der, Gorp, M. van, and Grootenhuis, M.
- Abstract
Contains fulltext : 295976.pdf (Publisher’s version ) (Open Access), BACKGROUND: This study compares a comprehensive range of psychosocial outcomes of adult childhood cancer survivors (CCS) to general population-based references and identifies sociodemographic and medical risk factors. METHODS: CCS from the Dutch Childhood Cancer Survivor Study (DCCSS)-LATER cohort (diagnosed 1963-2001) part 2 (attained age ≥18 years, diagnosed <18 years, ≥5 years since diagnosis) completed the Rosenberg Self-Esteem Scale, Hospital Anxiety and Depression Scale, Distress Thermometer, Self-Rating Scale for Post-Traumatic Stress Disorder, and the Short Form-36 (Health Related Quality of Life). CCS' scores were compared with references using analysis of variances and logistic regression analysis, controlling for age and sex (p < .05). Risk factors for worse psychosocial outcomes were assessed with regression analyses (p < .05). RESULTS: CCS, N = 1797, mean age 35.4 years, 49.0% female, all ≥15 years since diagnosis, participated. Three percent reported posttraumatic stress disorder because of childhood cancer and 36.6% experienced clinical distress. CCS did not differ from references on self-esteem and anxiety but were less depressed (d = -.25), and scored poorer on all health-related quality of life scales, except for bodily pain (.01 ≤ d ≥ -.36). Female sex, lower educational attainment, not being in a relationship, and being unemployed were negatively associated with almost all psychosocial outcomes. Except for a central nervous system tumor diagnosis, few medical characteristics were associated with psychosocial outcomes. CONCLUSION: CCS appear resilient regarding mental health but have slightly poorer health-related quality of life than references. Sociodemographic characteristics and central nervous system tumors were related to most psychosocial outcomes, but no clear pattern was observed for other medical factors. Future studies should address additional factors in explaining CCS' psychosocial functioning, such as coping, social support, and ph
- Published
- 2023
18. Responsible governance for data-intensive health research networks: A learning approach
- Author
-
Delden, J.J.M. van, Schillemans, T., Thiel, G.J.M.W. van, Mostert, M., Muller, Sam Hendrik Adriaan, Delden, J.J.M. van, Schillemans, T., Thiel, G.J.M.W. van, Mostert, M., and Muller, Sam Hendrik Adriaan
- Published
- 2023
19. Positive and negative survivor-specific psychosocial consequences of childhood cancer: the DCCSS-LATER 2 psycho-oncology study
- Author
-
Maas, A., Maurice-Stam, H., Aa-van Delden, A.M. van der, Dalen, E.C. van, Dulmen-den Broeder, E. van, Tissing, W.J.E., Loonen, J.J., Pal, H.J.H. van der, Vries, A.C.H. de, Heuvel-Eibrink, M.M. van den, Janssens, G.O., Ronckers, C., Neggers, S., Bresters, D., Louwerens, M., Versluys, B.A.B., Heiden-van der Loo, M. van der, Kremer, L.C.M., Gorp, M. van, Grootenhuis, M.A., and Dutch LATER Study Group
- Subjects
Quality of life ,Impact of cancer ,Long-term survivorship ,Childhood cancer survivors ,Psychosocial - Abstract
Purpose: Numerous studies investigated generic psychosocial outcomes in survivors of childhood cancer (CCS). The present study aimed to describe survivor-specific psychosocial consequences in CCS, and to identify socio-demographic and medical associated factors. Methods: CCS from the Dutch Childhood Cancer Survivor Study (DCCSS)-LATER cohort (diagnosed 1963-2001) part 2 (age >= 18 years, diagnosed < 18 years, >= 5 years since diagnosis) completed the Benefit & Burden Scale (BBSC) and the Impact of Cancer-Childhood Cancer (IOC-CS). Items were scored on a 5-point Likert scale (range 1-5). We examined outcomes with descriptive statistics, and socio-demographic and medical associated factors with regression analyses, corrected for multiple testing (p < 0.004). Results: CCS, N = 1713, age mean (M) 36 years, 49% female, >= 15 years since diagnosis, participated. On average, CCS reported 'somewhat' Benefit (M = 2.9), and 'not at all' to 'a little' Burden (M = 1.5) of childhood cancer. Average scores on IOC-CS' positive impact scales ranged from 2.5 (Personal Growth) to 4.1 (Socializing), and on the negative impact scales from 1.4 (Financial Problems) to 2.4 (Thinking/Memory). Apart from cognitive problems, CCS reported challenges as worries about relationship status, fertility, and how cancer had affected siblings. Female sex was associated with more Personal Growth, and more negative impact. CCS more highly educated, partnered, and employed had higher positive and lower negative impact. CCS older at diagnosis reported more positive impact. CNS tumor survivors and those who had head/cranium radiotherapy had higher negative impact. CNS tumor survivors reported less positive impact. Conclusion and implications: The majority of CCS reported positive impact of cancer while most CCS reported little negative impact. While this may indicate resiliency in most CCS, health care providers should be aware that they can also experience survivor-specific challenges that warrant monitoring/screening, information provision and psychosocial support.
- Published
- 2023
20. Accuracy of Estimated Ratios as Affected by Dynamic Classification Errors.
- Author
-
Delden, Arnout van, Scholtus, Sander, Burger, Joep, and Meertens, Quinten
- Subjects
- *
TAYLOR'S series , *GROSS domestic product , *NAIVE Bayes classification , *STATISTICAL bias - Abstract
Within the field of official statistics, we are often interested in the relative change of statistical indicators through time. A typical example is economic growth measured as the ratio of gross domestic product at two consecutive time periods. In this article, we investigate the accuracy of such ratios when the numerator and denominator describe a subpopulation. Subpopulations are always identified by a classification variable, which might contain classification errors. Our main objective is to quantify the bias and variance of statistical estimates of ratios of statistical indicators that are affected by classification errors. Previous studies have already shown how to estimate the bias and variance of statistical indicators for a single subpopulation as affected by classification errors. For estimated ratios, such results are not yet available in the academic literature. In this article, we will provide those results. More specifically, we will investigate three situations: the classification errors for the numerator and denominator are (1) completely dependent, (2) completely independent, or (3) partially dependent. For these three cases, we derive estimators of the bias and variance using a Taylor expansion and a bootstrap approach. By means of a simulation study, we show that the Taylor expansion is valid unless the distribution of the target variable of the numerator or the denominator is highly skewed. The methods are applied to two widely differing case studies: one on classification errors made by a machine learning classifier (independent errors) and one on classification errors in register data (partially dependent errors). This illustrates that our method can be useful for a wide range of applications. [ABSTRACT FROM AUTHOR]
- Published
- 2023
- Full Text
- View/download PDF
21. Textile meets plastics
- Author
-
Delden, Hendrik van, primary
- Published
- 2023
- Full Text
- View/download PDF
22. Perioperatives immunoinflammatorisches Monitoring von Patienten mit terminaler Niereninsuffizienz und Nierentransplantation
- Author
-
Delden, Dustin van
- Subjects
FOS: Medical and Health Sciences ,Nierentransplantation, Endotoxin, Endotoxin Activity Assay (EAA), Inflammation, Niereninsuffizienz - Abstract
Die chronische Inflammation stellt in der Therapie der terminalen Niereninsuffizienz eine große therapeutische Herausforderung dar. Als ein wichtiger Faktor hierfür konnte eine erhöhte Endotoxinämie identifiziert werden, die einen wesentlichen Risikofaktor für die erhöhte kardiovaskuläre Mortalität von Hämodialyse-Patienten darstellt, als auch den Erfolg von Nierentransplantation bezüglich Überleben und Graft-Funktion gefährden kann. Bisherige Nachweismethoden einer Endotoxinämie sind in ihrer Herstellung sehr aufwendig und kostenintensiv. Eine neue Nachweismethode, das Endotoxin Activity Assay (EAA), fußt auf der Reaktion von Granulozyten auf Endotoxine und konnte in bisherigen Studien valide Ergebnisse erzielen. Ziel dieser Studie war es, diese neue Nachweis-Methode für die Untersuchung der Endotoxinämie bei dialysepflichtigen und nierentransplantierten Patienten zu evaluieren und in einen Gesamtkontext zu patientenbezogenen Daten, Laborwerten und klinischen Ereignissen zu stellen. Der EAA kann keine wesentlichen Veränderungen der Endotoxin-Aktivität im Rahmen einer Dialyse-Behandlung feststellen. Ebenso zeigen sich die EAA-Werte von klinischen und patienten-bezogenen Parametern unabhängig. Im Unterschied zu anderen publizierten Ergebnissen konnte ebenfalls keine generelle Immunaktivierung anhand des EAA-Wertes bei Dialyse-Patienten ermittelt werden. Ein direkter Vergleich der auf unterschiedlichen Arten gemessenen Endotoxinämien ist zum gegenwärtigen Zeitpunkt nur sehr eingeschränkt möglich. Im postoperativen Verlauf von Nierentransplantationen können erhöhte Endotoxinwerte mit der Eintrittswahrscheinlichkeit von postoperativen Transplantations-Komplikationen, wie Transplantat-Abstoßungen oder Verlust der Transplantat-Funktion signifikant in Zusammenhang gebracht werden. Eine weitere Einbettung der EAA-Werte mit klinischen verfügbaren Laborwerten oder patientenbezogenen Daten ist nur in unzureichendem Maße möglich. Mit Hilfe dieser zweigliedrigen Studie konnten neue Erkenntnisse sowohl bezüglich der Endotoxinämie bei dialysepflichtigen Patienten als auch des immunoinflammatorischen Zustands nierentransplantierter Patienten gewonnen werden. Weitere Analysen hätten zur Aufgabe, diese neue Nachweisemethode zur Endotoxinämie neben den terminal nierenerkrankten Patienten auch auf andere Patientengruppen mit erhöhtem Risiko für Komplikationen aufgrund vorangegangener Immunstimulationen anzuwenden.
- Published
- 2023
- Full Text
- View/download PDF
23. Study protocol for a multicentre nationwide prospective cohort study to investigate the natural course and clinical outcome in benign liver tumours and cysts in the Netherlands: the BELIVER study
- Author
-
Furumaya, A., Haring, M.P.D., Rosmalen, B.V. van, Klompenhouwer, A.J., Besselink, M.G., Man, R.A. de, IJzermans, J.N.M., Thomeer, M.G.J., Kramer, M., Coolsen, M.M.E., Tushuizen, M.E., Schaapherder, A.F., Haas, R.J. de, Duiker, E.W., Kazemier, G., Delden, O.M. van, Verheij, J., Takkenberg, R.B., Cuperus, F.J.C., Meijer, V.E. de, Erdmann, J.I., Dutch Benign Liver Tumor Grp DBLTG, Faculteit Medische Wetenschappen/UMCG, Center for Liver, Digestive and Metabolic Diseases (CLDM), Surgery, Gastroenterology & Hepatology, Radiology & Nuclear Medicine, MUMC+: MA Maag Darm Lever (9), MUMC+: MA Heelkunde (9), MUMC+: MA AIOS Heelkunde (9), RS: FHML non-thematic output, CCA - Cancer Treatment and quality of life, Pathology, Targeted Gynaecologic Oncology (TARGON), Groningen Institute for Organ Transplantation (GIOT), Graduate School, CCA - Cancer Treatment and Quality of Life, Amsterdam Gastroenterology Endocrinology Metabolism, Radiology and Nuclear Medicine, Amsterdam Cardiovascular Sciences, Cancer Center Amsterdam, and Gastroenterology and Hepatology
- Subjects
Adenoma ,Cysts ,Netherlands/epidemiology ,General Medicine ,hepatobiliary tumours ,hepatobiliary surgery ,hepatobiliary disease ,Liver Neoplasms/surgery ,Cohort Studies ,Observational Studies as Topic ,Liver Cell/surgery ,Humans ,Multicenter Studies as Topic ,Prospective Studies ,Adenoma, Liver Cell/surgery - Abstract
IntroductionBenign liver tumours and cysts (BLTCs) comprise a heterogeneous group of cystic and solid lesions, including hepatic haemangioma, focal nodular hyperplasia and hepatocellular adenoma. Some BLTCs, for example, (large) hepatocellular adenoma, are at risk of complications. Incidence of malignant degeneration or haemorrhage is low in most other BLTCs. Nevertheless, the diagnosis BLTC may carry a substantial burden and patients may be symptomatic, necessitating treatment. The indications for interventions remain matter of debate. The primary study aim is to investigate patient-reported outcomes (PROs) of patients with BLTCs, with special regards to the influence of invasive treatment as compared with the natural course of the disease.Methods and analysisA nationwide observational cohort study of patients with BLTC will be performed between October 2021 and October 2026, the minimal follow-up will be 2 years. During surveillance, a questionnaire regarding symptoms and their impact will be sent to participants on a biannual basis and more often in case of invasive intervention. The questionnaire was previously developed based on PROs considered relevant to patients with BLTCs and their caregivers. Most questionnaires will be administered by computerised adaptive testing through the Patient-Reported Outcomes Measurement Information System. Data, such as treatment outcomes, will be extracted from electronic patient files. Multivariable analysis will be performed to identify patient and tumour characteristics associated with significant improvement in PROs or a complicated postoperative course.Ethics and disseminationThe study was assessed by the Medical Ethics Committee of the University Medical Center Groningen and the Amsterdam UMC. Local consultants will provide information and informed consent will be asked of all patients. Results will be published in a peer-reviewed journal.Study registrationNL8231—10 December 2019; Netherlands Trial Register.
- Published
- 2022
24. Vaccination of the Immunocompromised Patient
- Author
-
Vaudaux, Bernard P., primary, Bühler, Silja, additional, Delden, Christian Van, additional, and Berger, Christoph, additional
- Published
- 2017
- Full Text
- View/download PDF
25. Bacteremia During the First Year After Solid Organ Transplantation: An Epidemiological Update.
- Author
-
Neofytos, Dionysios, Stampf, Susanne, Hoessly, Linard D, D'Asaro, Matilde, Tang, Gael Nguyen, Boggian, Katia, Hirzel, Cedric, Khanna, Nina, Manuel, Oriol, Mueller, Nicolas J, Delden, Christian Van, and Study, for the Swiss Transplant Cohort
- Abstract
Background There are limited contemporary data on the epidemiology and outcomes of bacteremia in solid organ transplant recipients (SOTr). Methods Using the Swiss Transplant Cohort Study registry from 2008 to 2019, we performed a retrospective nested multicenter cohort study to describe the epidemiology of bacteremia in SOTr during the first year post-transplant. Results Of 4383 patients, 415 (9.5%) with 557 cases of bacteremia due to 627 pathogens were identified. One-year incidence was 9.5%, 12.8%, 11.4%, 9.8%, 8.3%, and 5.9% for all, heart, liver, lung, kidney, and kidney-pancreas SOTr, respectively (P =.003). Incidence decreased during the study period (hazard ratio, 0.66; P <.001). One-year incidence due to gram-negative bacilli (GNB), gram-positive cocci (GPC), and gram-positive bacilli (GPB) was 5.62%, 2.81%, and 0.23%, respectively. Seven (of 28, 25%) Staphylococcus aureus isolates were methicillin-resistant, 2/67 (3%) enterococci were vancomycin-resistant, and 32/250 (12.8%) GNB produced extended-spectrum beta-lactamases. Risk factors for bacteremia within 1 year post-transplant included age, diabetes, cardiopulmonary diseases, surgical/medical post-transplant complications, rejection, and fungal infections. Predictors for bacteremia during the first 30 days post-transplant included surgical post-transplant complications, rejection, deceased donor, and liver and lung transplantation. Transplantation in 2014–2019, CMV donor-negative/recipient-negative serology, and cotrimoxazole Pneumocystis prophylaxis were protective against bacteremia. Thirty-day mortality in SOTr with bacteremia was 3% and did not differ by SOT type. Conclusions Almost 1/10 SOTr may develop bacteremia during the first year post-transplant associated with low mortality. Lower bacteremia rates have been observed since 2014 and in patients receiving cotrimoxazole prophylaxis. Variabilities in incidence, timing, and pathogen of bacteremia across different SOT types may be used to tailor prophylactic and clinical approaches. [ABSTRACT FROM AUTHOR]
- Published
- 2023
- Full Text
- View/download PDF
26. Bloodstream infections in allogeneic haematopoietic cell recipients from the Swiss Transplant Cohort Study
- Author
-
Weisser, Maja, primary, Sava, Mihaela, additional, Baettig, Veronika, additional, Gerull, Sabine, additional, Passweg, Jakob, additional, Khanna, Nina, additional, Garzoni, Christian, additional, Gerber, Bernhard, additional, Mueller, Nicolas, additional, Schanz, Urs, additional, Berger, Christoph, additional, Chalandon, Yves, additional, Delden, Christian van, additional, Neofytos, Dionysios, additional, Stampf, Susanne, additional, and Franzeck, Fabian, additional
- Published
- 2022
- Full Text
- View/download PDF
27. The Effects of Soil Improving Cropping Systems (SICS) on Soil Erosion and Soil Organic Carbon Stocks across Europe: A Simulation Study
- Author
-
Baartman, Jantiene E. M., primary, Nunes, Joao Pedro, additional, Delden, Hedwig van, additional, Vanhout, Roel, additional, and Fleskens, Luuk, additional
- Published
- 2022
- Full Text
- View/download PDF
28. Participating in your own surveillance within a smart city environment: a look at Brainport Smart District
- Author
-
Delden, T.H.A. van, Delden, T.H.A. van, Delden, T.H.A. van, and Delden, T.H.A. van
- Published
- 2020
29. Study protocol: adjuvant holmium-166 radioembolization after radiofrequency ablation in early-stage hepatocellular carcinoma patients-a dose-finding study (HORA EST HCC Trial)
- Author
-
Hendriks, P., Rietbergen, D.D.D., Erkel, A.R. van, Coenraad, M.J., Arntz, M., Bennink, R.J., Braat, A.E., Crobach, A., Delden, O.M. van, Hulle, T. van der, Klumpen, H.J., Meer, R.W. van der, Nijsen, J.F.W., Rijswijk, C.S.P. van, Roosen, J., Ruijter, B.N., Smit, F., Stam, M.K., Takkenberg, R.B., Tushuizen, M.E., Velden, F.H.P. van, Geus-Oei, L.F. de, Burgmans, M.C., Cholangiocarcinoma, G. Dutch Hepatocel, Internal medicine, Radiology and Nuclear Medicine, AGEM - Amsterdam Gastroenterology Endocrinology Metabolism, CCA -Cancer Center Amsterdam, ACS - Amsterdam Cardiovascular Sciences, Oncology, CCA - Cancer Treatment and Quality of Life, and Gastroenterology and Hepatology
- Subjects
Radioisotopes ,Carcinoma, Hepatocellular ,Hepatocellular carcinoma ,Liver Neoplasms ,Other Research Radboud Institute for Health Sciences [Radboudumc 0] ,Radiofrequency ablation ,Embolization, Therapeutic ,Thermal ablation ,Women's cancers Radboud Institute for Health Sciences [Radboudumc 17] ,TARE ,Holmium ,Tumours of the digestive tract Radboud Institute for Health Sciences [Radboudumc 14] ,Treatment Outcome ,Urological cancers Radboud Institute for Health Sciences [Radboudumc 15] ,Catheter Ablation ,Humans ,Tissue Distribution ,Radiology, Nuclear Medicine and imaging ,Prospective Studies ,Radioembolization ,Cardiology and Cardiovascular Medicine ,Early-stage HCC ,Holmium-166 ,Retrospective Studies - Abstract
Purpose To investigate the biodistribution of holmium-166 microspheres (166Ho-MS) when administered after radiofrequency ablation (RFA) of early-stage hepatocellular carcinoma (HCC). The aim is to establish a perfused liver administration dose that results in a tumoricidal dose of holmium-166 on the hyperaemic zone around the ablation necrosis (i.e. target volume). Materials and Methods This is a multicentre, prospective, dose-escalation study in HCC patients with a solitary lesion 2–5 cm, or a maximum of 3 lesions of ≤ 3 cm each. The day after RFA patients undergo angiography and cone-beam CT (CBCT) with (super)selective infusion of technetium-99 m labelled microalbumin aggregates (99mTc-MAA). The perfused liver volume is segmented from the CBCT and 166Ho-MS is administered to this treatment volume 5–10 days later. The dose of holmium-166 is escalated in a maximum of 3 patient cohorts (60 Gy, 90 Gy and 120 Gy) until the endpoint is reached. SPECT/CT is used to determine the biodistribution of holmium-166. The endpoint is met when a dose of ≥ 120 Gy has been reached on the target volume in 9/10 patients of a cohort. Secondary endpoints include toxicity, local recurrence, disease-free and overall survival. Discussion This study aims to find the optimal administration dose of adjuvant radioembolization with 166Ho-MS after RFA. Ultimately, the goal is to bring the efficacy of thermal ablation up to par with surgical resection for early-stage HCC patients. Trial registration Clinicaltrials.gov identifier: NCT03437382.
- Published
- 2022
30. Asking the right questions: towards a person-centered conception of shared decision-making regarding treatment of advanced chronic kidney disease in older patients
- Author
-
Verberne, W.R., Stiggelbout, A.M., Bos, W.J.W., and Delden, J.J.M. van
- Subjects
Male ,Person-centered care ,Health (social science) ,Health Policy ,Issues, ethics and legal aspects ,Renal Dialysis ,Older patients ,Humans ,Female ,Renal Insufficiency, Chronic ,Conservative care ,Decision Making, Shared ,Dialysis ,Shared decision-making ,Aged - Abstract
An increasing number of older patients have to decide on a treatment plan for advanced chronic kidney disease (CKD), involving dialysis or conservative care. Shared decision-making (SDM) is recommended as the model for decision-making in such preference-sensitive decisions. The aim of SDM is to come to decisions that are consistent with the patient’s values and preferences and made by the patient and healthcare professional working together. In clinical practice, however, SDM appears to be not yet routine and needs further implementation. A shift from a biomedical to a person-centered conception might help to make the process more shared. Shared should, therefore, be interpreted as two persons bringing two perspectives to the table, that both need to be explored during the decision-making process. Starting from the patient’s perspective will enable to determine the mutual goals of care first and, subsequently, determine the best way for achieving those goals. To perform such SDM, the healthcare professional needs to become a skilled companion, being part of the patient’s relational context, and start asking the right questions about what matters to the patient as person. In this article, we describe the need for a person-centered conception of SDM for the setting of older patients with advanced CKD.
- Published
- 2022
31. The variability of Sahelian rainfall: an analysis using a long-term high spatial resolution moisture tracking method
- Author
-
Keulers, Sander, Delden, A.J. van (Thesis Advisor), Keulers, Sander, and Delden, A.J. van (Thesis Advisor)
- Published
- 2022
32. Collaborative goal-setting: stakeholders’ experiences, barriers and facilitators.
- Author
-
Sangster, Vera, Delden, J.J.M. van (Thesis Advisor), Sangster, Vera, and Delden, J.J.M. van (Thesis Advisor)
- Abstract
Background: Goal-setting is an approach that encourages the use of self-defined goals of care in the process of decision-making. It is already a commonly known concept in rehabilitation and end-of life care. Several positive effects have been listed in previous research. At University Medical Center Utrecht it appears that only few doctors document goals of care in patient records. This study aims to identify stakeholders’ experiences with goal-setting and the barriers and facilitators to discussing, documenting and using goals of care in individual health care. Methods: A qualitative study design was used. In-depth topic-interviews were held with 19 healthcare professionals (HCPs) and 7 patients. Results: Although the majority of HCPs and patients share a positive attitude towards goal-setting, it appears hard to accomplish. This study identified that that most HCPs are not consistent in discussing values, preferences and goals with their patients. Many different barriers to goalsetting are identified, including the ambiguity concerning the interpretation of goals, organisational barriers, patient-related barriers and the uncertainty about the usefulness and feasibility of goal-setting in every setting or situation. Most stakeholders agree that the current methods of goal-setting are not adequate. Conclusion: Based on our findings, the formulation of purely medical goals might be useful to improve communication between HCPs and provide clarity to patients. However, purely medical goals attribute less to performing care that is person-centered. Further research is recommended to identify ways to overcome the barriers and to develop a strategy for meaningful goal-setting in different care settings.
- Published
- 2022
33. Using Patient Knowledge in Patient Participation: Can a capabilities approach provide an equitable design for patient participation and avoid epistemic injustice?
- Author
-
Wijck, Nikè van, Delden, J.J.M. van (Thesis Advisor), Wijck, Nikè van, and Delden, J.J.M. van (Thesis Advisor)
- Abstract
This thesis provides an epistemological and ethical analysis of the use of the concepts ‘experience’, ‘experiential knowledge’ and ‘experiential expertise’ within patient participation in The Netherlands. It shows how the use of these concepts can provoke epistemic injustice being done to patients by creating hierarchies of epistemic positions and by exclusion of marginalised groups. It is argued that instead of experiential knowledge, we should start using the term ‘patient knowledge’. In order to do this it is examined whether a capabilities approach could be a suitable theoretical framework to involve patient knowledge into care in a morally just way. Therefore, three arguments in favour of– and against– a capabilities approach are introduced, exploring if it can provide an equitable design for reshaping patient participation policies within The Netherlands. It was concluded that an essentialist capabilities approach can provide an equitable framework for patient participation on an institutional (macro) level. At an individual (micro) level, it can provide a starting point for the conversation between physicians and patients, but leaves the freedom to interpret the framework to the patient and the physician. The task of the physicians is to create the space for good communication, by, for instance, using tools as a prelude for the conversation or by the acquisition of both moral and epistemic virtues.
- Published
- 2022
34. Requests for euthanasia or assisted suicide of people without (severe) illness
- Author
-
Berg, V.E. van den, Zomers, Margot, Thiel, Ghislaine van, Leget, C.J.W., Delden, J.J.M. van, Wijngaarden, E.J. Van, Berg, V.E. van den, Zomers, Margot, Thiel, Ghislaine van, Leget, C.J.W., Delden, J.J.M. van, and Wijngaarden, E.J. Van
- Abstract
Item does not contain fulltext
- Published
- 2022
35. Meaningful Respect for the Autonomy of Persons with 'Completed Life': An Analysis in Light of Empirical Research
- Author
-
Zomers, M.L., Wijngaarden, E.J. Van, Delden, J.J.M. van, Thiel, G. van, Zomers, M.L., Wijngaarden, E.J. Van, Delden, J.J.M. van, and Thiel, G. van
- Abstract
Item does not contain fulltext
- Published
- 2022
36. Study Protocol PROMETHEUS: Prospective Multicenter Study to Evaluate the Correlation Between Safety Margin and Local Recurrence After Thermal Ablation Using Image Co-registration in Patients with Hepatocellular Carcinoma
- Author
-
Oosterveer, T.T.M., Erp, G.C.M. van, Hendriks, P., Broersen, A., Overduin, C.G., Rijswijk, C.S.P. van, Erkel, A.R. van, Meer, R.W. van der, Tushuizen, M.E., Moelker, A., Meijerink, M.R., Delden, O.M. van, Jong, K.P. de, Leij, C. van der, Smits, M.L.J., Urlings, T.A.J., Braak, J., Meershoek-Klein Kranenbarg, E., Duijn-de Vreugd, B. van, Zeijdner, E., Goeman, J.J., Futterer, J.J., Coenraad, M.J., Dijkstra, J., Burgmans, M.C., Oosterveer, T.T.M., Erp, G.C.M. van, Hendriks, P., Broersen, A., Overduin, C.G., Rijswijk, C.S.P. van, Erkel, A.R. van, Meer, R.W. van der, Tushuizen, M.E., Moelker, A., Meijerink, M.R., Delden, O.M. van, Jong, K.P. de, Leij, C. van der, Smits, M.L.J., Urlings, T.A.J., Braak, J., Meershoek-Klein Kranenbarg, E., Duijn-de Vreugd, B. van, Zeijdner, E., Goeman, J.J., Futterer, J.J., Coenraad, M.J., Dijkstra, J., and Burgmans, M.C.
- Abstract
Contains fulltext : 252031.pdf (Publisher’s version ) (Open Access), PURPOSE: The primary objective is to determine the minimal ablation margin required to achieve a local recurrence rate of < 10% in patients with hepatocellular carcinoma undergoing thermal ablation. Secondary objectives are to analyze the correlation between ablation margins and local recurrence and to assess efficacy. MATERIALS AND METHODS: This study is a prospective, multicenter, non-experimental, non-comparative, open-label study. Patients > 18 years with Barcelona Clinic Liver Cancer stage 0/A hepatocellular carcinoma (or B with a maximum of two lesions < 5 cm each) are eligible. Patients will undergo dual-phase contrast-enhanced computed tomography directly before and after ablation. Ablation margins will be quantitatively assessed using co-registration software, blinding assessors (i.e. two experienced radiologists) for outcome. Presence and location of recurrence are evaluated independently on follow-up scans by two other experienced radiologists, blinded for the quantitative margin analysis. A sample size of 189 tumors (~ 145 patients) is required to show with 80% power that the risk of local recurrence is confidently below 10%. A two-sided binomial z-test will be used to test the null hypothesis that the local recurrence rate is >/= 10% for patients with a minimal ablation margin >/= 2 mm. Logistic regression will be used to find the relationship between minimal ablation margins and local recurrence. Kaplan-Meier estimates are used to assess local and overall recurrence, disease-free and overall survival. DISCUSSION: It is expected that this study will result in a clear understanding of the correlation between ablation margins and local recurrence. Using co-registration software in future patients undergoing ablation for hepatocellular carcinoma may improve intraprocedural evaluation of technical success. Trial registration The Netherlands Trial Register (NL9713), https://www.trialregister.nl/trial/9713 .
- Published
- 2022
37. Extrahepatic Disease in Hepatocellular Carcinoma: Do We Always Need Whole-Body CT or Is Liver MRI Sufficient? A Subanalysis of the SORAMIC Trial
- Author
-
Geyer, Thoma, Kazmierczak, Philipp M, Steffen, Ingo G, Malfertheiner, Peter, Peynircioglu, Bora, Loewe, Christian, Delden, Otto van, Vandecaveye, Vincent, Gebauer, Bernhard, Pech, Maciej, Sengel, Christian, Bargellini, Irene, Iezzi, Roberto, Benito, Alberto, Zech, Christoph J, Gasbarrini, Antonio, Schütte, Kerstin, Ricke, Jen, Seidensticker, Max, Iezzi, Roberto (ORCID:0000-0002-2791-481X), Gasbarrini, Antonio (ORCID:0000-0002-7278-4823), Geyer, Thoma, Kazmierczak, Philipp M, Steffen, Ingo G, Malfertheiner, Peter, Peynircioglu, Bora, Loewe, Christian, Delden, Otto van, Vandecaveye, Vincent, Gebauer, Bernhard, Pech, Maciej, Sengel, Christian, Bargellini, Irene, Iezzi, Roberto, Benito, Alberto, Zech, Christoph J, Gasbarrini, Antonio, Schütte, Kerstin, Ricke, Jen, Seidensticker, Max, Iezzi, Roberto (ORCID:0000-0002-2791-481X), and Gasbarrini, Antonio (ORCID:0000-0002-7278-4823)
- Abstract
Background: To investigate whole-body contrast-enhanced CT and hepatobiliary contrast liver MRI for the detection of extrahepatic disease (EHD) in hepatocellular carcinoma (HCC) and to quantify the impact of EHD on therapy decision. Methods: In this post-hoc analysis of the prospective phase II open-label, multicenter, randomized controlled SORAMIC trial, two blinded readers independently analyzed the whole-body contrast-enhanced CT and gadoxetic acid-enhanced liver MRI data sets of 538 HCC patients. EHD (defined as tumor manifestation outside the liver) detection rates of the two imaging modalities were compared using multiparametric statistical tests. In addition, the most appropriate treatment recommendation was determined by a truth panel. Results: EHD was detected significantly more frequently in patients with portal vein infiltration (21% vs. 10%, p < 0.001), macrovascular infiltration (22% vs. 9%, p < 0.001), and bilobar liver involvement (18% vs. 9%, p = 0.006). Further on, the maximum lesion diameter in patients with EHD was significantly higher (8.2 cm vs. 5.8 cm, p = 0.002). CT detected EHD in significantly more patients compared to MRI in both reader groups (p < 0.001). Higher detection rates of EHD in CT led to a change in management only in one patient since EHD was predominantly present in patients with locally advanced HCC, in whom palliative treatment is the standard of care. Conclusions: Whole-body contrast-enhanced CT shows significantly higher EHD detection rates compared to hepatobiliary contrast liver MRI. However, the higher detection rate did not yield a significant impact on patient management in advanced HCC.
- Published
- 2022
38. Droogte in de Achterhoek | Een onderzoek naar de aanpak van een sluipende crisis met een focus op temporaliteit
- Author
-
Delden, Hannah van, Vis, Barbara (Thesis Advisor), Delden, Hannah van, and Vis, Barbara (Thesis Advisor)
- Abstract
Crises worden gekenmerkt door dreiging, urgentie en onzekerheid. Ze kunnen voor komen in acute of in sluipende vorm. De sluipende crisis, waarbij de temporele factor anders ligt dan bij een acute crisis, wordt vaak minder urgent geacht, waardoor een treffende aanpak uitblijft. Over het treffend aanpakken van een sluipende crisis is relatief weinig bekend binnen de literatuur. Het is interessant om te onderzoeken of het creëren van langetermijnbeleid kan helpen bij de aanpak van een sluipende crisis, vanwege het vergelijkbare temporele aspect: gericht op een ruime tijdshorizon. Het ontwikkelen van langetermijnbeleid is geen gemakkelijke opgave, maar niet onmogelijk. Vier factoren die het ontwikkelen van dergelijk beleid bevorderen worden besproken in dit onderzoek: electorale zekerheid, zicht op winsten van het beleid, institutionele capaciteit en framing. Mogelijk kan er bij de aanpak van een sluipende crisis worden geleerd van de ontwikkeling van langetermijnbeleid. Dit vraagstuk staat centraal in dit onderzoek. Door middel van een kwalitatieve casestudy is gekeken in hoeverre inzichten over het creëren van langetermijnbeleid kunnen helpen bij de aanpak van een sluipende crisis. Deze vraag is onderzocht aan de hand van de casus ‘droogte in de Achterhoek’. Droogte in de Achterhoek kan worden beschouwd als een sluipende crisis. De aanpak krijgt vorm via een samenwerking tussen 19 partijen, bestaande uit onder andere provincie, gemeenten, waterschap en verschillende belangenorganisaties. Uit het onderzoek blijkt dat twee van de factoren die van invloed zijn op het creëren van langetermijnbeleid zeer relevant zijn (of minstens kunnen zijn) voor de aanpak van droogte in de Achterhoek: framing en capaciteit. Framing wordt niet bewust ingezet, maar er wordt bewust gewerkt aan beeldvorming en bepaalde woorden worden bewust gekozen of weggelaten. Bij capaciteit speelt in de Achterhoek voornamelijk het tekort aan goed personeel. De andere twee factoren bleken (op dit moment)
- Published
- 2022
39. Experience of paediatric healthcare professionals with the questionnaire ‘’We would like to know you!’’
- Author
-
Morgan-Owen, Charlotte, Delden, J.J.M. van (Thesis Advisor), Morgan-Owen, Charlotte, and Delden, J.J.M. van (Thesis Advisor)
- Abstract
Introduction: Person-centred care is considered to be the core of healthcare, drawing attention to values and preferences of patients regarding their healthcare. Person-centred care plays an equally important role in paediatric healthcare, particularly in potential additional communicative difficulties for paediatric patients to convey their wishes. Implementation of the questionnaire ‘’We would like to know you!’’ aims to support person-centred care for paediatric patients. This study investigates the user experience of the questionnaire and the extent to which it supports person-centred care from the perspective of the healthcare professional. Method: A retrospective interview content analysis was conducted, using a qualitative narrative research method. Healthcare professionals were interviewed according to a topic list. Results: Eleven healthcare professionals were interviewed, including doctors, nurses and educational workers. The questionnaire’s overall use indicated a low level of application, partly due to its’ early stage of implementation and the choice to approach only new patients. However, the majority of those utilizing the questionnaire found it practical in use, providing additional information in either getting to know their patient, facilitate contact or as a way of being alerted of children or topics in need of additional attention during consultation. Conclusion: Based on these findings, the questionnaire could contribute to supporting more person-centred care. However, when primarily approached as a tool to improve efficiency in healthcare, person-centred care could be diminished. Future research is recommended on a larger group of participants, further identifying the various ways the questionnaire is utilized to support its’ aim of more person-centred care.
- Published
- 2022
40. Making it Rain in the Desert: Fantasy or Future
- Author
-
Warnau, Sarah, Delden, A.J. van (Thesis Advisor), Warnau, Sarah, and Delden, A.J. van (Thesis Advisor)
- Abstract
Regreening initiatives are being undertaken as climate change mitigation strategies, to improve water and food security, and to increase biodiversity. Because of positive feedback loops between vegetation and precipitation, regreening has the potential to lead to the restoration of local and regional water cycles. However, in arid and hyper-arid regions, the amount of available rainwater is not sufficient to sustain the initial stages of regreening. A technology that uses solar energy to evaporate seawater may be able to enhance convective rainfall. The main research question is: Can evaporation through technology potentially be used for water cycle restoration in arid and hyper-arid regions? Using atmospheric boundary layer theories as described by Stull (1988), a simple atmospheric column model was developed and coupled to a surface model with a dynamic vegetation component. Results of sensitivity analyses with this numerical model show the importance of atmospheric conditions and it is found that evaporation through technology has the potential to be effective in regions with a relatively moist and cold atmosphere. Regions that satisfy these conditions and also have a dry soil are mostly found 25-35°N near coasts and/or in mountainous areas. One such area is the Sinai Peninsula. Numerical simulations using ERA5 reanalysis data as boundary conditions show that the evaporation technology can increase precipitation locally, but this increase is small. However, because of the wind directed southward and up the mountain range of South Sinai, the technology has the potential to cause precipitation non-locally as well as is shown by simulations where the atmospheric column is moved along a streamline. In conclusion, enhanced evaporation through technology has the potential to be used for regreening projects if atmospheric conditions are favorable. However, more research is needed and the potential adverse effects, such as warming, need to be taken into consideration.
- Published
- 2022
41. Extrahepatic Disease in Hepatocellular Carcinoma: Do We Always Need Whole-Body CT or Is Liver MRI Sufficient? A Subanalysis of the SORAMIC Trial
- Author
-
Geyer, Thomas, primary, Kazmierczak, Philipp M., additional, Steffen, Ingo G., additional, Malfertheiner, Peter, additional, Peynircioglu, Bora, additional, Loewe, Christian, additional, Delden, Otto van, additional, Vandecaveye, Vincent, additional, Gebauer, Bernhard, additional, Pech, Maciej, additional, Sengel, Christian, additional, Bargellini, Irene, additional, Iezzi, Roberto, additional, Benito, Alberto, additional, Zech, Christoph J., additional, Gasbarrini, Antonio, additional, Schütte, Kerstin, additional, Ricke, Jens, additional, and Seidensticker, Max, additional
- Published
- 2022
- Full Text
- View/download PDF
42. Octavio Paz: Literature, Modernity, Institutions
- Author
-
Delden, Maarten van, primary
- Published
- 2016
- Full Text
- View/download PDF
43. Gadoxetic Acid-Based MRI for Decision-Making in Hepatocellular Carcinoma Employing Perfusion Criteria Only—A Post Hoc Analysis from the SORAMIC Trial Diagnostic Cohort
- Author
-
Seidensticker, Max, primary, Steffen, Ingo G., additional, Bargellini, Irene, additional, Berg, Thomas, additional, Benito, Alberto, additional, Gebauer, Bernhard, additional, Iezzi, Roberto, additional, Loewe, Christian, additional, Karçaaltincaba, Musturay, additional, Pech, Maciej, additional, Sengel, Christian, additional, Delden, Otto van, additional, Vandecaveye, Vincent, additional, Zech, Christoph J., additional, and Ricke, Jens, additional
- Published
- 2022
- Full Text
- View/download PDF
44. Einfluss der antihypertensiven Medikation auf die Screening-Parameter bei Patienten mit und ohne primären Hyperaldosteronismus
- Author
-
Delden, Yolande van
- Subjects
FOS: Medical and Health Sciences - Published
- 2021
- Full Text
- View/download PDF
45. Survival Benefit of Repeat Local Treatment in Patients Suffering From Early Recurrence of Colorectal Cancer Liver Metastases.
- Author
-
Hellingman, T., Kuiper, B.I., Buffart, L.M., Meijerink, M.R., Versteeg, K.S., Swijnenburg, R.J., Delden, O.M. van, Haasbeek, C.J.A., Vries, J.J.J. de, Waesberghe, J.H. van, Zonderhuis, B.M., Vliet, H.J. van der, Kazemier, G., Hellingman, T., Kuiper, B.I., Buffart, L.M., Meijerink, M.R., Versteeg, K.S., Swijnenburg, R.J., Delden, O.M. van, Haasbeek, C.J.A., Vries, J.J.J. de, Waesberghe, J.H. van, Zonderhuis, B.M., Vliet, H.J. van der, and Kazemier, G.
- Abstract
01 december 2021, Contains fulltext : 244864.pdf (Publisher’s version ) (Open Access), BACKGROUND: A uniform treatment strategy for patients suffering from early recurrence after local treatment of CRLM is currently lacking. The aim of this observational cohort study was to assess the potential survival benefit of repeat local treatment compared to systemic therapy in patients suffering from early recurrence of CRLM. PATIENTS AND METHODS: Patients who developed recurrent CRLM within 12 months after initial local treatment with curative intent were retrospectively identified in Amsterdam University Medical Centers between 2009-2019. Differences in overall and progression-free survival among treatment strategies were assessed using multivariable Cox regression analyses. RESULTS: A total of 135 patients were included. Median overall survival of 41 months [range 4-135] was observed in patients who received repeat local treatment, consisting of upfront or repeat local treatment after neoadjuvant systemic therapy, compared to 24 months [range 1-55] in patients subjected to systemic therapy alone (adjusted HR = 0.42 [95%-CI: 0.25-0.72]; P = .002). Prolonged progression-free survival was observed after neoadjuvant systemic therapy followed by repeat local treatment, as compared to upfront repeat local treatment in patients with recurrent CRLM within 4 months following initial local treatment of CRLM (adjusted HR = 0.36 [95%-CI: 0.15-0.86]; P = .021). CONCLUSION: Patients with early recurrence of CRLM should be considered for repeat local treatment strategies. A multimodality approach, consisting of neoadjuvant systemic therapy followed by repeat local treatment, appeared favorable in patients with recurrence within 4 months following initial local treatment of CRLM.
- Published
- 2021
46. De pandemie als spiegel: Bestuurskundig leren van de aanpak van de COVID-19-crisis
- Author
-
Delden, M. van, Hendrikx, P.M.A., Keulemans, S.A.C., Steen, M.A. van der, Delden, M. van, Hendrikx, P.M.A., Keulemans, S.A.C., and Steen, M.A. van der
- Abstract
Contains fulltext : 245168.pdf (Publisher’s version ) (Open Access)
- Published
- 2021
47. Radiofrequency ablation and chemotherapy versus chemotherapy alone for locally advanced pancreatic cancer (PELICAN): study protocol for a randomized controlled trial
- Author
-
Walma, M.S., Rombouts, S.J., Brada, L.J.H., Rinkes, I.H.M. Borel, Bosscha, K., Bruijnen, R.C., Busch, O.R., Creemers, G.J., Daams, F., Dam, R.M. van, Delden, O.M. van, Festen, S., Ghorbani, P., Groot, D.J.A. de, Groot, J.W.B. de, Mohammad, N. Haj, Hillegersberg, R. van, Hingh, I.H.J.T. de, D'Hondt, M., Kerver, E.D., Leeuwen, M.S. van, Liem, M.S., Lienden, K.P. van, Los, M., Meijer, V.E. de, Meijerink, M.R., Mekenkamp, L.J., Nio, C.Y., Abdennabi, I. Oulad, Pando, E., Patijn, G.A., Polée, M.B., Pruijt, J.F., Roeyen, G., Ropela, J.A., Stommel, M.W.J., Vos-Geelen, J. de, Vries, J.J.J. de, Waal, E.M. van der, Wessels, F.J., Wilmink, J.W., Santvoort, H.C. van, Besselink, M.G.H., Molenaar, I.Q., Walma, M.S., Rombouts, S.J., Brada, L.J.H., Rinkes, I.H.M. Borel, Bosscha, K., Bruijnen, R.C., Busch, O.R., Creemers, G.J., Daams, F., Dam, R.M. van, Delden, O.M. van, Festen, S., Ghorbani, P., Groot, D.J.A. de, Groot, J.W.B. de, Mohammad, N. Haj, Hillegersberg, R. van, Hingh, I.H.J.T. de, D'Hondt, M., Kerver, E.D., Leeuwen, M.S. van, Liem, M.S., Lienden, K.P. van, Los, M., Meijer, V.E. de, Meijerink, M.R., Mekenkamp, L.J., Nio, C.Y., Abdennabi, I. Oulad, Pando, E., Patijn, G.A., Polée, M.B., Pruijt, J.F., Roeyen, G., Ropela, J.A., Stommel, M.W.J., Vos-Geelen, J. de, Vries, J.J.J. de, Waal, E.M. van der, Wessels, F.J., Wilmink, J.W., Santvoort, H.C. van, Besselink, M.G.H., and Molenaar, I.Q.
- Abstract
Contains fulltext : 239066.pdf (Publisher’s version ) (Open Access), BACKGROUND: Approximately 80% of patients with locally advanced pancreatic cancer (LAPC) are treated with chemotherapy, of whom approximately 10% undergo a resection. Cohort studies investigating local tumor ablation with radiofrequency ablation (RFA) have reported a promising overall survival of 26-34 months when given in a multimodal setting. However, randomized controlled trials (RCTs) investigating the effect of RFA in combination with chemotherapy in patients with LAPC are lacking. METHODS: The "Pancreatic Locally Advanced Unresectable Cancer Ablation" (PELICAN) trial is an international multicenter superiority RCT, initiated by the Dutch Pancreatic Cancer Group (DPCG). All patients with LAPC according to DPCG criteria, who start with FOLFIRINOX or (nab-paclitaxel/)gemcitabine, are screened for eligibility. Restaging is performed after completion of four cycles of FOLFIRINOX or two cycles of (nab-paclitaxel/)gemcitabine (i.e., 2 months of treatment), and the results are assessed within a nationwide online expert panel. Eligible patients with RECIST stable disease or objective response, in whom resection is not feasible, are randomized to RFA followed by chemotherapy or chemotherapy alone. In total, 228 patients will be included in 16 centers in The Netherlands and four other European centers. The primary endpoint is overall survival. Secondary endpoints include progression-free survival, RECIST response, CA 19.9 and CEA response, toxicity, quality of life, pain, costs, and immunomodulatory effects of RFA. DISCUSSION: The PELICAN RCT aims to assess whether the combination of chemotherapy and RFA improves the overall survival when compared to chemotherapy alone, in patients with LAPC with no progression of disease following 2 months of systemic treatment. TRIAL REGISTRATION: Dutch Trial Registry NL4997 . Registered on December 29, 2015. ClinicalTrials.gov NCT03690323 . Retrospectively registered on October 1, 2018.
- Published
- 2021
48. Oostelijke faseverschuiving planetaire golven als oorzaak of gevolg van zonaal asymmetrische klimaatopwarming op gemiddelde breedtegraad van het noordelijk halfrond in april
- Author
-
Hubers, D.B.A., Delden, A.J. van (Thesis Advisor), Hubers, D.B.A., and Delden, A.J. van (Thesis Advisor)
- Abstract
De temperatuur in West-Europa stijgt in april sneller dan jaargemiddeld. Bovendien warmt West-Europa in april sneller op dan andere gebieden op dezelfde breedtegraad, zoals Oost-Canada. In dit verslag bespreek ik of een toename van zuidelijke wind door versterking of oostelijke verschuiving van de trog van planetaire golven rond West-Europa als consequentie van veranderde sneeuwbedekking een oorzaak of gevolg is van de zonaal asymmetrische opwarming en de versterkte opwarming in april van West-Europa. Met behulp van hoofdcomponentanalyse blijkt er een zwak statistisch verband te zijn tussen (i) de temperatuur in West-Europa en de sneeuwbedekking op Eurazië en (ii) de temperatuur in Oost-Canada en sneeuwbedekking op Noord-Amerika. Door het weergeven van de zonaal gemiddelde v-component van de wind in april als functie van de lengtegraad, volgt dat er sprake is van een oostelijke verschuiving van het de trog boven de Atlantische oceaan. Er is geen tot weinig verschuiving van de trog in Oost-Canada. Daardoor is er sprake van meer zuidelijke wind in april in West-Europa. Door het bepalen van de lokale tijdafgeleide van de temperatuur blijkt echter dat de term afhankelijk van de meridionale snelheid juist afneemt met de tijd voor West-Europa. Zo volgt dat er sprake is van een longitudinaal homogenere temperatuurverdeling met de jaren waardoor de zuidelijke wind als gevolg van oostelijke verplaatsing van de trog niet de oorzaak kan zijn van de versterkte temperatuurtoename in West-Europa in april. Wel is er in april een toename gemeten van de verticale windsnelheid in De Bilt en Goose, welke wel een bijdrage levert aan de toegenomen temperaturen in april ten opzichte van het jaargemiddelde.
- Published
- 2021
49. Wind farm power production reduction by the wake effect in Harmonie.
- Author
-
Zoer, T., Theeuwes, N. (Thesis Advisor), Delden, A. van, Zoer, T., Theeuwes, N. (Thesis Advisor), and Delden, A. van
- Abstract
This study investigates how the loss in power production of offshore wind farms, caused by the wake effect, depends on the stability of the atmospheric boundary layer. A windfarm parameterization is used in HARMONIE-AROME, an operational numerical weather prediction model. Three experiments are performed — a control run without turbines, a default wind farm run with turbines installed until January 1 2019 and a future run that consist of a possible scenario for 2050 — in the German Bight for a selection of hours in2019, where wind direction ranges between 78.75-101.25°, wind speed from 8 to 16 m s-1 and the atmospheric boundary layer is considered unstable when RIB, the Bulk Richardson number, < 0, neutral when 0 ≤ RIB ≤ 0.2 or stable when RIB > 0.2. First the performance of the wind farm parameterization is evaluated with measurement of wind speed at FINO1, a research platform 45 km north of Borkum. We find that the default run performs better than the control run, as for all stabilities the bias and mean absolute error at 91 m and 34 m height are reduced. Then, the dependency of the wind farm wake on atmospheric stability is examined. We conclude that our method to define the wake area performs good and the wake area is larger in stable atmospheres where turbulent mixing is suppressed. Finally, the dependency of the power production loss on atmospheric stability is investigated. The median relative production loss for all wind farms under investigation combined is 31.5% for stable hours, 25.5% for neutral hours and 17% for unstable hours.
- Published
- 2021
50. The local climate on the East Antarctic Plateau in relation to large scale flow patterns
- Author
-
Bohn, L.G., Tijm-Reijmer, C.H. (Thesis Advisor), Delden, A.J. van, Bohn, L.G., Tijm-Reijmer, C.H. (Thesis Advisor), and Delden, A.J. van
- Abstract
Although the density of observation sites is low on the East Antarctic Plateau, there are several locations at which meteorological observations are conducted. These observations provide insights into the local climate, and are invaluable for evaluating climate models and satellite observations. Additionally, the ERA5 reanalysis dataset from the European Centre for Medium-range Weather Forecasts (ECMWF) may enable these records to be extended with longer time series and far more complete spatial coverage, providing further insights into local climate conditions. The main purpose of this study is to obtain a better understanding of the variability and trends in local climate on the East Antarctic Plateau, and therefore better understand how conditions on the East Antarctic Plateau react to changes in climate. The first step toward this goal is to assess the agreement between observational records and ERA5 data for the parameters of interest – air temperature, surface pressure, and wind speed – in order to determine whether the ERA5 data are suitable for extending these records. The next step is to analyze the available data by examining climatological averages, comparing conditions at different sites, and investigating variability and trends. In the final step, local variables are examined in relation to indices representing two large-scale atmospheric flow patterns that are known to impact the Antarctic climate: the Southern Annular Mode (SAM) index and the Southern Oscillation Index (SOI). Despite the fact that comparisons between observations and ERA5 data are imperfect, there is often fairly good agreement between them, particularly for air temperature and surface pressure. While no statistically significant temporal trends are found in monthly mean (potential) temperature at any site for either observations or ERA5, some significant temporal trends are found for wind speed in both datasets at some sites, which could be connected to an upward trend in the SAM in
- Published
- 2021
Catalog
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.